Two compounds target drug-resistant brain cancer cells in laboratory tests
Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths. The current standard of care involves the use of temozolomide (TMZ), a chemotherapy medication. However, the tumor can be difficult to control because cancer cells evolve to…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Bariatric surgery is effective rescue strategy after GLP-1 receptor agonist failure
Health
Medicine
Global
-
Is shorter daylight dragging down your mood? What to know about seasonal affective disorder
Health
Mental Health
-
The 10 Best Deodorants for Sensitive Skin, According to Dermatologists
-
Bombas vs. Ugg Boots: A Shopping Editor Compares the New Lookalikes to the OGs
Culture & Lifestyle
Fashion
-
Mother and baby's immune cells linked to aggressive placental inflammation in preterm cases
Science
Research
Global
-
Four ways thinking like a strategist can make you a better padel player
Sports
Tennis
-
Blood protein panel outperforms leading ALS biomarker in distinguishing patients from healthy individuals
Science
Research
United States
-
Drug restores kidney cell function in experimental models of rare Lowe syndrome
Health
Medicine